PHARMACOKINETICS OF HYDROXYETHYL STARCH IN NORMAL SUBJECTS

被引:52
作者
YACOBI, A [1 ]
STOLL, RG [1 ]
SUM, CY [1 ]
LAI, C [1 ]
GUPTA, SD [1 ]
HULSE, JD [1 ]
机构
[1] AMER CRIT CARE,DEPT RES & DEV,MCGRAW PK,IL 60085
关键词
D O I
10.1002/j.1552-4604.1982.tb02164.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:206 / 212
页数:7
相关论文
共 18 条
[1]  
BALDERSAVINI RJ, 1980, PHARM BASIS THERAPEU, V6, P395
[2]  
BERNFELD P, 1951, ADV ENZYMOL REL S BI, V12, P379
[3]   FATE OF 14C-LABELED HYDROXYETHYL STARCH IN ANIMALS [J].
BOGAN, RK ;
GALE, GR ;
WALTON, RP .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1969, 15 (01) :206-&
[4]   INTRAVASCULAR PERSISTENCE OF HYDROXYETHYL STARCH IN MAN [J].
BOON, JC ;
JESCH, F ;
RING, J ;
MESSMER, K .
EUROPEAN SURGICAL RESEARCH, 1976, 8 (06) :497-503
[5]  
Dagher F J, 1965, Adv Surg, V1, P69
[6]  
Doumas B. T., 1972, STAND METHODS CLIN C, V7, P175, DOI [10.1016/B978-0-12-609107-6.50022-2, DOI 10.1016/B978-0-12-609107-6.50022-2]
[7]  
GOFFERJE H, 1977, INFUSIONSTHERAPIE, V4, P141
[8]  
HULSE JD, 1980, RES COMMUN CHEM PATH, V29, P149
[9]  
KOEHLER H, 1977, International Journal of Clinical Pharmacology and Biopharmacy, V15, P428
[10]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265